Absence of heme oxygenase‐1 exacerbates atherosclerotic lesion formation and vascular remodeling

To examine the role of heme oxygenase (HO)‐1 in the pathophysiology of vascular diseases, we generated mice deficient in both HO‐1 and apolipoprotein E (HO‐1−/−apoE−/−). Despite similar total plasma cholesterol levels in response to hypercholesterolemia, HO‐1−/−apoE−/− mice, in comparison with HO‐1+/+apoE−/− mice, had an accelerated and more advanced atherosclerotic lesion formation. In addition to greater lipid accumulation, these advanced lesions from HO‐1−/−apoE−/− mice contained macrophages and smooth muscle α‐actin‐positive cells. We further tested the role of HO‐1 on neointimal formation in a mouse model of vein graft stenosis. Autologous vein grafts in HO‐1−/− mice showed robust neointima consisting of α‐actin‐positive vascular smooth muscle cells (VSMC) 10 days after surgery in comparison to the smaller neointima formed in autologous vein grafts in HO‐1+/+ mice. However, at 14 days after surgery, the neointima from composite vessels of HO‐1−/− mice was composed mainly of acellular material, indicative of substantial VSMC death. VSMC isolated from HO‐1−/− mice were susceptible to oxidant stress, leading to cell death. Our data demonstrate that HO‐1 plays an essential protective role in the pathophysiology of atherosclerosis and vein graft stenosis.

[1]  S. Kourembanas,et al.  Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. , 1995, The Journal of clinical investigation.

[2]  A. Lusis,et al.  Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. , 1997, The Journal of clinical investigation.

[3]  T. Lüscher,et al.  Pulsatile Stretch Stimulates Superoxide Production and Activates Nuclear Factor-κB in Human Coronary Smooth Muscle , 1997 .

[4]  S. Shyue,et al.  Adenovirus-Mediated Heme Oxygenase-1 Gene Transfer Inhibits the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice , 2001, Circulation.

[5]  Jason L. Johnson,et al.  Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. , 2001, Atherosclerosis.

[6]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Circulation.

[7]  J. Ingwall,et al.  Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice , 2001, Circulation research.

[8]  H. Rennke,et al.  Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice , 2001, Circulation research.

[9]  F. Kronenberg,et al.  Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. , 2001, Atherosclerosis.

[10]  L. Kobzik,et al.  Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. , 1999, The Journal of clinical investigation.

[11]  James L. Park,et al.  Heme oxygenase-1 protects against vascular constriction and proliferation , 2001, Nature Medicine.

[12]  A. Choi,et al.  Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway , 2000, Nature Medicine.

[13]  A. Choi,et al.  Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. , 1996, American journal of respiratory cell and molecular biology.

[14]  O. Wagner,et al.  Heme Oxygenase-1 Gene Promoter Microsatellite Polymorphism is Associated with Restenosis after Percutaneous Transluminal Angioplasty , 2001, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[15]  R. Alexander,et al.  Functional angiotensin II receptors in cultured vascular smooth muscle cells , 1982, The Journal of cell biology.

[16]  H. Marver,et al.  The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Y. Bobryshev,et al.  Structural features of cell death in atherosclerotic lesions affecting long-term aortocoronary saphenous vein bypass grafts. , 1999, Journal of submicroscopic cytology and pathology.

[18]  C. T. Wagner,et al.  Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. , 1997, The Journal of clinical investigation.

[19]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[20]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Y. Niida,et al.  Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. , 1999, The Journal of clinical investigation.

[23]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[24]  S. Tonegawa,et al.  Heme oxygenase 1 is required for mammalian iron reutilization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Beyar,et al.  Multivessel coronary artery disease: current revascularization strategies. , 2001, European heart journal.

[26]  G. Angelini,et al.  Towards the treatment of saphenous vein bypass graft failure--a perspective of the Bristol Heart Institute. , 2002, Biorheology.

[27]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[28]  S. Kourembanas,et al.  Carbon Monoxide Controls the Proliferation of Hypoxic Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[29]  Tzong-Shyuan Lee,et al.  Expression of heme oxygenase-1 in atherosclerotic lesions. , 1998, The American journal of pathology.

[30]  W. Pan,et al.  Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients , 2002, Human Genetics.

[31]  T. Minamino,et al.  Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L. Ny,et al.  Pitfalls using metalloporphyrins in carbon monoxide research. , 1997, Trends in pharmacological sciences.

[33]  P. Carmeliet,et al.  Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis. , 1999, Circulation research.

[34]  A. Lusis,et al.  Heme Oxygenase-1 Inhibits Atherosclerotic Lesion Formation in LDL-Receptor Knockout Mice , 2001, Circulation research.

[35]  D. Praticò,et al.  Effect of Low-Dose Aspirin on Vascular Inflammation, Plaque Stability, and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice , 2002, Circulation.

[36]  R. Tyrrell,et al.  Rapidly occurring DNA excision repair events determine the biological expression of u.v.-induced damage in human cells. , 1987, Carcinogenesis.

[37]  G. Angelini,et al.  Towards the prevention of vein graft failure. , 1997, International journal of cardiology.

[38]  R. Ross,et al.  Cell biology of atherosclerosis. , 1995, Annual review of physiology.

[39]  M. Mayr,et al.  Rapid development of vein graft atheroma in ApoE-deficient mice. , 2000, The American journal of pathology.

[40]  M. Suematsu,et al.  Increased Expression of Heme Oxygenase-1 and Bilirubin Accumulation in Foam Cells of Rabbit Atherosclerotic Lesions , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[41]  D. Sugawara,et al.  Heme Oxygenase-1 Inhibits Atherogenesis in Watanabe Heritable Hyperlipidemic Rabbits , 2001, Circulation.

[42]  S. Hunt,et al.  Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[43]  B. Ames,et al.  Antioxidant activity of albumin-bound bilirubin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[45]  E. Haber,et al.  Aortic Carboxypeptidase-like Protein, a Novel Protein with Discoidin and Carboxypeptidase-like Domains, Is Up-regulated during Vascular Smooth Muscle Cell Differentiation* , 1998, The Journal of Biological Chemistry.

[46]  B. Schreiber,et al.  Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  G. D. De Meyer,et al.  Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. , 1996, Circulation.

[48]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[49]  M. Maines Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[51]  P. Quax,et al.  Accelerated Atherosclerosis and Calcification in Vein Grafts: A Study in APOE*3 Leiden Transgenic Mice , 2002, Circulation research.

[52]  Tzong-Shyuan Lee,et al.  Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. , 1999, Circulation.